First-year Geisel medical student Patrick Tolosky believes empowerment through health and wellbeing can be an effective avenue toward breaking the cycle of poverty—it’s why he wants to become a physician.
Experiences such as working as a volunteer on medical mission trips to Honduras and practicing as an oncology nurse in Arizona helped Meghan Bullock ’20 decide that medical school was the right path for her.
Meet some of the members of the Geisel School of Medicine’s Class of 2021—KC Collier, Tianrae Chu, and Allie Morgan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine.
When Bill Eidtson, Geisel’s director of learning support and accessibility services, talks about his interest in education, the conversation is punctuated with lively observations on educational technology and satire, which on the surface appear to be unrelated. However, he believes they can help people develop critical thinking skills.
Geisel School of Medicine Dean Duane Compton, PhD, announced today that Gregory Ogrinc, MD, MS, an internationally recognized innovator in medical education, has been name the Senior Associate Dean for Medical Education, a role that he has served in on an interim basis since 2014.
Meet some of the members of the Geisel School of Medicine’s Class of 2021—Sand Mastrangelo, Shuaibu Ali, Sylvia Guerra, and Meredith Ryan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine
Dartmouth’s Graduate Program in Quantitative Biomedical Sciences (QBS) is offering a new master’s degree with a concentration in health data science beginning in fall 2018.
The 92 members of the Geisel School of Medicine Class of 2021 ended their first full week of classes on a high note as they donned the symbol of their new profession.
Project 439 seeks to stem the rising tide of opioid overdose deaths in New Hampshire while helping those struggling with substance abuse protect their health.
Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.